Bmxtm1.1Npa
Targeted Allele Detail
|
Symbol: |
Bmxtm1.1Npa |
Name: |
BMX non-receptor tyrosine kinase; targeted mutation 1.1, Novartis Pharma AG |
MGI ID: |
MGI:5013470 |
Synonyms: |
BMXtm1(K421R)Npa |
Gene: |
Bmx Location: ChrX:162975838-163041189 bp, - strand Genetic Position: ChrX, 76.12 cM, cytoband F
|
Alliance: |
Bmxtm1.1Npa page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:173099
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
BALB/c
|
|
Allele Type: |
|
Targeted |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Mutation details: Nucleotides substitutions in exon 14 result in the amino acid substitution of arginine for lysine at position 421 (K421R). This mutation responds to the human mutation K445R that results in the loss of kinase activity. A floxed neo cassette was removed by cre-mediated recombination.
(J:173099)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Bmx Mutation: |
12 strains or lines available
|
|
Original: |
J:173099 Gottar-Guillier M, et al., The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner. J Immunol. 2011 May 15;186(10):6014-23 |
All: |
2 reference(s) |
|